CTIC

CELL THERAPEUTICS INC Financials

moreView todays social media effects on CTICView the latest stocks trending across Twitter. Click to view dashboardSee who Cell is hiring next, click here to view […]

Cell Therapeutics CEO Discusses Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Jim Bianco Thank you, M and good afternoon everyone. As most of you know CTI is a biopharmaceutical company with one marketed oncology drug and an exciting late-stage pipeline. Our focus is to become a … moreView todays social media effects on CTICView the latest stocks trending across Twitter. Click to view dashboardSee who Cell is […]

PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

[PR Newswire] – BIRMINGHAM, England, April 29, 2014 /PRNewswire/ — Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the launch of PIXUVRI® (pixantrone), the first new treatment for adult patients in the United Kingdom (UK) with mult moreView todays social media effects on CTICView the latest stocks trending across Twitter. Click to view dashboardSee who Cell is hiring […]

Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014

[PR Newswire] – SEATTLE, April 22, 2014 /PRNewswire/ — Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its first quarter 2014 financial results on Tuesday, April 29, 2014, after … moreView todays social media effects on CTICView the latest stocks trending across Twitter. Click to view dashboardSee who Cell is hiring next, click here […]